Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-10-11
1995-01-10
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 530306, 530324, 530325, A61K 3700, A61K 3702
Patent
active
053807103
ABSTRACT:
Pharmaceutical compositions containing ACTH(1-24) are effective in the treatment of shock conditions and of respiratory and cardiocirculatory insufficiency. The compositions of the invention may be administered by parenteral or inhalatory route at a dosage ranging from 1 to 10 mg of active principle.
REFERENCES:
patent: 3228839 (1966-01-01), Kappeler et al.
patent: 3352844 (1967-11-01), Boissonnas et al.
patent: 3632743 (1972-01-01), Geller et al.
patent: 4112073 (1978-09-01), Ono et al.
patent: 4113858 (1978-09-01), Hashim
patent: 4410511 (1983-10-01), de Wied et al.
patent: 4594329 (1986-06-01), Vale Jr. et al.
patent: 4794103 (1988-12-01), Bertolini
patent: 4794104 (1988-12-01), Bertolini
patent: 5013721 (1991-05-01), Melchioni et al.
Felber et al,"Administration by Nasal Spray of an 18 amino acid synthetic polypeptide with corticotropic action," Experientia vol. 25, No. 11, pp. 1195-1196, 1969.
Resusiscitation, 18 (1989). pp. 145-147; pp. 149-150,; pp. 321-326 Elsevier Scientific Publishers Ireland Ltd.
Mohamed Abdei A.
Schneider Walter H.
Wityshyn Michael G.
LandOfFree
Pharmaceutical compositions containing ACTH (1-24) for the thera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing ACTH (1-24) for the thera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing ACTH (1-24) for the thera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-850638